State Street International Developed Equity Index Portfolio
STATE STREET MASTER FUNDS
Fund classification
Classified from what the fund holds · as of 2026 Q2
State Street International Developed Equity Index Portfolio is a developed international equity index fund.
- Asset class
- Equity
- Region
- Developed international
- Management
- Index (passive)
- Fund type
- Open-end fund
- Features
- Master-feeder
Fund profile
This fund files no prospectus profile. Unit investment trusts and closed-end funds register on forms that carry no objective or fee tagging, and some fund families file without it — a gap in what was filed, not a fund without an objective or without fees.
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 97.19% |
| Cash & short-term | 3.34% |
| Derivatives | 0.01% |
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Largest new: Resonac Holdings Corp, Furukawa Electric Co Ltd, Telecom Italia SpA/Milano, Mitsui Kinzoku Co Ltd, Enlight Renewable Energy Ltd, PLS Group Ltd, Wise Group PLC, Millicom International Cellular SA
Largest exited: Telecom Italia SpA/Milano, Wise PLC, Nice Ltd, Tokyu Corp, Sekisui Chemical Co Ltd, Sony Financial Group Inc, Shimadzu Corp, MatsukiyoCocokara & Co
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| — | ASML Holding NV | 3.44% | $1,968.08 | $153.24M | 77.9K |
| GVMXX | State Street Global AdvisorsGVMXX | 3.34% | — | $148.62M | — |
| — | HSBC Holdings PLC | 1.47% | $18.99 | $65.32M | 3.4M |
| — | Roche Holding AG | 1.30% | $412.57 | $58.03M | 140.7K |
| — | Novartis AG | 1.29% | $156.92 | $57.54M | 366.7K |
| — | AstraZeneca PLC | 1.27% | $187.14 | $56.66M | 302.8K |
| — | Nestle SA | 1.19% | $102.99 | $53.14M | 515.9K |
| — | Siemens AG | 1.07% | $321.44 | $47.83M | 148.8K |
| — | Shell PLC | 0.98% | $38.93 | $43.79M | 1.1M |
| — | Tokyo Electron Ltd | 0.96% | $474.70 | $42.63M | 89.8K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 16.33% of net assets, top 25 28.08%, across 668 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free